Bb Biotech Ag

BB Biotech AG publishes its interim report and revises its dividend policy

July 24, 2026

BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning

July 24, 2026

BB Biotech : Interim Report (BION2026 Q1 en)

April 24, 2026

BB Biotech AG publishes its interim report

April 24, 2026

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.25 per share

March 19, 2026

BION:SIX

CH · CHF

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

BBZA:XETR

DE · EUR

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

BBZA:GETTEX

DE · EUR

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

BBZA:TRADEGATE

DE · EUR

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

A0NFN3:LS

DE · EUR

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

BBZA:FWB

DE · EUR

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

0JYO:LSIN

GB · CHF

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

A0NFN3:LSX

DE · EUR

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

BBZA:BX

CH · CHF

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

BBZA:DUS

DE · EUR

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

BION:VIE

AT · EUR

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.

BBZA:SWB

DE · EUR

Alternate listing for Bb Biotech Ag; the primary context on this page is BIONZ:AQUISUK.